Bristol-Myers Squibb Company (BMY) New York Stock Exchange
51.560.641.26%
CloseDecember 18, 2018

News: updated – 19-Dec 04:08


Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical Holdings Co., Ltd to Purchase UPSA19-Dec 03:30(Business Wire)

Strategic review process announced in June concludes with a project to sell UPSA consumer health business The potential transaction would position Bristol-Myers Squibb to further refine its portfolio to focus on transformational medicines for patients facing serious diseases …

The New Generex: Unlocking The Value18-Dec 12:50(SeekingAlpha)

The principal research of Generex Biotechnology ( GNBT ) for years has been its buccal delivery system. The buccal tissue is the tissue on the inside of the cheek and under the tongue. Generex buccal delivery sprays a solution under a high gas aerosol formulation containing a drug on to the bl…